Skip to main content
. 2017 May 1;11(5):FC10–FC14. doi: 10.7860/JCDR/2017/25129.9818

[Table/Fig-6]:

Frequency (f) percentage (%) distribution of patients based on the adverse effects in the two groups.

Sl. no Adverse effects Category of drugs
Ondansetron (n=106) Palonosetron (n=106)
(f) (%) (f) (%)
1. Headache 18 17 10 9.4
2. Constipation 9 8.5 5 4.7
3. Diarrhoea 2 1.9 0 0
4. Abdominal pain 5 4.7 1 0.9
5. Dry mouth 3 2.8 6 5.7